Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Post Traumatic Stress Disorder

In brief

A Double-Blind Placebo-Controlled Random Order Crossover Pilot Study of Iloperidone for Symptoms of Arousal in PTSD.

Key facts

Study ID

NCT01917318

Run by

University of Colorado, Denver

People needed

1

Starts

2013-07-01

Expected to finish

2014-02-01

Last updated by the study team

2020-02-11

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• PTSD diagnosis

You may not qualify if…

• Pregnancy
• Traumatic Brain Injury greater than mild
• Primary sleep disorder
• Caffeinism
• Active substance use disorder
• Active suicidal risk
• Antipsychotic medication, antibiotics, sedatives, some antihypertensive or antiarrhythmic medication

Where it is running

• University of Colorado Depression Center; Clinical and Translational Research Center (CTRC) — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.